MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 13.11.2025
Celcuity EV 2011-2025 | CELC
EV Jährlich Celcuity
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 506 M | 451 M | 181 M | 68.1 M | 140 M | 99.8 M | 209 M | 133 M | 445 K | 284 K | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 506 M | 284 K | 179 M |
EV anderer Aktien in der Diagnostik & Forschung
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Brainsway Ltd.
BWAY
|
223 M | $ 17.12 | 0.91 % | $ 99.4 M |  Israel |
 |
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
DarioHealth Corp.
DRIO
|
6.61 M | $ 12.08 | 1.6 % | $ 343 M | Israel |
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M |  Canada |
 |
DexCom
DXCM
|
52.4 B | $ 66.05 | -1.36 % | $ 25.5 B |  USA |
 |
Burning Rock Biotech Limited
BNR
|
433 M | $ 16.21 | 2.92 % | $ 174 M |  China |
 |
Exact Sciences Corporation
EXAS
|
12.2 B | $ 101.54 | 0.04 % | $ 18.8 B | USA |
 |
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
35.7 M | $ 1.57 | -2.88 % | $ 2 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M |  Britain |
 |
Castle Biosciences
CSTL
|
665 M | $ 38.67 | 0.09 % | $ 1.07 B | USA |
 |
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | USA |
 |
Danaher Corporation
DHR
|
150 B | $ 226.56 | 0.1 % | $ 166 B | USA |
 |
Fulgent Genetics
FLGT
|
502 M | $ 26.89 | -0.92 % | $ 813 M | USA |
 |
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | USA |
 |
Mettler-Toledo International
MTD
|
33.2 B | $ 1 410.21 | 1.19 % | $ 29.9 B |  Schweiz |
 |
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | China |
 |
NeoGenomics
NEO
|
1.9 B | $ 12.03 | 1.52 % | $ 1.52 B | USA |
 |
Neogen Corporation
NEOG
|
2.26 B | $ 6.79 | -1.02 % | $ 1.47 B | USA |
 |
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
644 M | $ 19.88 | -3.31 % | $ 1.07 B | USA |
 |
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | USA |
 |
Pacific Biosciences of California
PACB
|
2.28 B | $ 2.12 | - | $ 538 M | USA |
 |
Anixa Biosciences
ANIX
|
1.5 M | $ 3.32 | -7.26 % | $ 106 K | USA |
 |
Co-Diagnostics
CODX
|
29.3 M | $ 0.31 | -9.29 % | $ 9.1 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
14.5 B | $ 26.44 | -0.56 % | $ 20 B |  Niderland |
 |
IQVIA Holdings
IQV
|
54.8 B | $ 222.81 | 0.27 % | $ 40.4 B | USA |
 |
Precipio
PRPO
|
10.9 M | $ 24.67 | -1.2 % | $ 32 M | USA |
 |
Quidel Corporation
QDEL
|
460 M | $ 28.84 | 0.14 % | $ 1.21 B | USA |
 |
QIAGEN N.V.
QGEN
|
11.3 B | $ 45.08 | -0.31 % | $ 10 B | Niderland |
 |
Guardant Health
GH
|
6.94 B | $ 103.85 | 1.74 % | $ 12.7 B | USA |
 |
Aspira Women's Health
AWH
|
42.8 M | - | -6.19 % | $ 10.5 M | USA |
 |
Sotera Health Company
SHC
|
5.87 B | $ 16.84 | 0.03 % | $ 4.76 B | USA |
 |
Soleno Therapeutics
SLNO
|
1.95 B | $ 49.87 | -4.1 % | $ 2 B | USA |
 |
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
15.3 B | $ 134.53 | -0.25 % | $ 21.4 B | USA |
 |
Charles River Laboratories International
CRL
|
12.4 B | $ 197.25 | 2.19 % | $ 10.1 B | USA |
 |
Thermo Fisher Scientific
TMO
|
202 B | $ 572.13 | 0.08 % | $ 219 B | USA |
 |
Trinity Biotech plc
TRIB
|
133 M | $ 0.96 | -10.3 % | $ 61.9 M |  Irlanda |
 |
Quotient Limited
QTNT
|
393 M | - | -11.32 % | $ 1.1 M | Schweiz |
 |
Twist Bioscience Corporation
TWST
|
1.55 B | $ 31.04 | 0.36 % | $ 1.86 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
18.5 B | $ 184.03 | 0.81 % | $ 20.4 B | USA |
|
Biodesix
BDSX
|
142 M | $ 7.57 | -3.57 % | $ 982 M | USA |
 |
Myriad Genetics
MYGN
|
1.2 B | $ 6.98 | -3.26 % | $ 632 M | USA |